These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25964963)

  • 1. Antithrombotic treatment after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):231. PubMed ID: 25964963
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.
    Gurbel PA; Tantry US
    Heart; 2016 Jun; 102(11):882-92. PubMed ID: 26944654
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
    Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
    EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 5. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 6. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 9. Use new antiplatelet therapies consistently in clinical practice.
    Aalbers J
    Cardiovasc J Afr; 2013 Apr; 24(3):100. PubMed ID: 23736138
    [No Abstract]   [Full Text] [Related]  

  • 10. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
    Gibson CM
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 14. Underuse of antithrombotic and antiplatelet treatments for acute coronary syndrome in China: a note of caution.
    Cheng TO
    Chin Med J (Engl); 2009 May; 122(9):1120. PubMed ID: 19493455
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium.
    Costa F; Brugaletta S
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):782-786. PubMed ID: 29705073
    [No Abstract]   [Full Text] [Related]  

  • 16. Current challenges and directions in antithrombotic therapy.
    Van de Werf F
    Timely Top Med Cardiovasc Dis; 2008 Jan; 12():E2. PubMed ID: 18392216
    [No Abstract]   [Full Text] [Related]  

  • 17. Rivaroxaban 2.5 mg. No justification for using this anticoagulant after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):229-32. PubMed ID: 25964962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
    Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
    EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of oral anticoagulants in patients after an acute coronary syndrome.
    Carreras ET; Mega JL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):520-4. PubMed ID: 25614282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bleeding risk related to combined aspirin and other antithrombotic drug use in patients with acute coronary syndrome: prevention and therapy strategies].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1057-9. PubMed ID: 21215136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.